Szostak Nobel prize in medicine

Jack W. Szostak, a geneticist at Harvard Medical School, is one of three co-winners of the 2009 prize.

Jack Szostak

Professor of genetics Jack W. Szostak has won the Nobel Prize in Physiology or Medicine with Elizabeth H. Blackburn (University of California, San Francisco) and Carol W. Greider (Johns Hopkins School of Medicine). The three scientists were recognized for their work on how chromosomes are protected by telomeres and the enzyme telomerase. Szostak's home page at Harvard Medical School details his recent work on the synthesis of life on earth: "the related challenges of understanding the origin of life on the early earth, and constructing synthetic cellular life in the laboratory." His lab home page is here; he is also a Howard Hughes Medical Institute investigator, and  has a biographical page there, emphasizing his current work on the origins of life and the re-creation of the first steps in biological synthesis. Harvard's Origins of Life Initiative is described here; Szostak is one of the affiliated faculty members.

According to the Nobel press release, the trio have solved a critical part of a fundamental problem in biology: "how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes--the telomeres--and in an enzyme that forms them – telomerase."


The explanation continues:

The long, thread-like DNA molecules that carry our genes are packed into chromosomes, the telomeres being the caps on their ends. Elizabeth Blackburn and Jack Szostak discovered that a unique DNA sequence in the telomeres protects the chromosomes from degradation. Carol Greider and Elizabeth Blackburn identified telomerase, the enzyme that makes telomere DNA. These discoveries explained how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase.


If the telomeres are shortened, cells age. Conversely, if telomerase activity is high, telomere length is maintained, and cellular senescence is delayed. This is the case in cancer cells, which can be considered to have eternal life. Certain inherited diseases, in contrast, are characterized by a defective telomerase, resulting in damaged cells. The award of the Nobel Prize recognizes the discovery of a fundamental mechanism in the cell, a discovery that has stimulated the development of new therapeutic strategies.

 

Related topics

You might also like

Are Creators the Future of Democracy?

A Harvard panel considers how “parasocial relationships” might drive democratic engagement.

Harvard Board of Overseers Candidates Describe Priorities

Alumni will vote for the University governing board in April and May.

Five Questions with Dick Friedman

Harvard Magazine’s longstanding football editor reflects on his career in journalism.

Most popular

Mark Carney on the Limits of Soft Power

At the 2026 Davos summit, the Canadian prime minister echoes Harvard’s Joseph Nye.

Why Men Are Falling Behind in Education, Employment, and Health

Can new approaches to education address a growing gender gap?

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.

Explore More From Current Issue

Cover of "Harvard's Best" featuring a woman in a red and black gown holding a sword.

A Forgotten Harvard Anthem

Published the year the Titanic sank, “Harvard’s Best” is a quizzical ode to the University.

An image depicting high carb ultra processed foods, those which are often associated with health risks

Is Ultraprocessed Food Really That Bad?

A Harvard professor challenges conventional wisdom. 

Historic church steeple framed by bare tree branches against a clear sky.

Harvard’s Financial Challenges Lead to Difficult Choices

The University faces the consequences of the Trump administration—and its own bureaucracy.